nutch_noindex
CANCEL
COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for children ages 6 months and older.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para niños de 6 meses en adelante.

/nutch_noindex

Manisha Newaskar, MD

  • “If I'm able to help a child with their breathing, the rest of the body benefits.”

When I was little, doctors were very respected in our community. I wanted to wear a white coat and a stethoscope just like them. Then I realized it's not just about wearing a white coat but about helping people.

Becoming a doctor is the best decision of my life, because I love what I'm doing. Breathing plays such an important role in overall health. When a child has trouble breathing, it impacts other aspects of their life. If I'm able to help a child with their breathing, the rest of the body benefits.

I know that families often wait a long time to see a specialist. I make sure they have enough time to share their concerns, and then we form a plan together.

I want parents to know that I treat each child as if they were my own. I have my own children, so I understand what parents go through. I want families to know they can call me anytime for any reason. They are a part of my family.

Specialties

Pulmonary

Work and Education

Professional Education

Mahatma Gandhi Memorial Medical College, Indore, India, 4/1/1995

Residency

Driscoll Foundation Children's Hospital, Corpus Christi, TX, 6/30/2004

Fellowship

UCSF Benioff Childrens Hospital Pediatric Pulmonary Fellowship, Oakland, CA, United States of America, 12/30/2007

Board Certifications

Pediatric Pulmonary, American Board of Pediatrics

Pediatrics, American Board of Pediatrics

Conditions Treated

Asthma

Cystic Fibrosis

All Publications

Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease PEDIATRIC PULMONOLOGY Bonnel, A. S., Song, S. M., Kesavarju, K., Newaskar, M., Paxton, C. J., Bloch, D. A., Moss, R. B., Robinson, T. E. 2004; 38 (5): 396-405

Abstract

The purpose of this study was to compare quantitative computed tomography air trapping (AT) and pulmonary function measurements between subjects with mild cystic fibrosis lung disease (MCF; forced expiratory volume in 1 sec (FEV1) > 70% predicted) and normal age-matched controls. Quantitative AT measurements at different levels of expiration were evaluated. Ten subjects from the MCF group and 10 normal subjects underwent inspiratory and expiratory spirometer-triggered chest high-resolution computed tomography (HRCT) and pulmonary function tests. Six matched CT images were obtained at full inflation and at a lung volume near residual volume (nRV). Quantitative measurements of AT were determined by evaluating expiratory CT lung density and by the percent of segmented lung which demonstrated AT on expiratory scans. Percent AT was evaluated for all lung slices combined (global AT), and also by regional assessment. Additional comparisons of lung density and percent air trapping were made in 10 CF subjects with three matched axial HRCT images at lung volumes corresponding to full inflation, near functional residual capacity (nFRC), and nRV. All measurements of expiratory lung density in CF subjects were significantly lower and % AT significantly higher than normal controls. Significant correlations for all subjects were observed between % global AT and RV/TLC as well as forced expiratory flow between 25-75% of forced vital capacity (FEF(25-75)) % predicted. Pulmonary density measurements and % AT better discriminated differences between groups than PFTs. Measurements made on expiratory scans near FRC showed significantly higher values for AT than those made near RV.

View details for DOI 10.1002/ppul.20091

View details for Web of Science ID 000224625500004

View details for PubMedID 15390349